logo

For the Inventor, By the Inventor

Seoul, South Korea

Il Dong Pharmaceutical Co., Ltd.


USPTO Granted Patents = 18



Trademarks = 8

Forward Citations = 4

Loading Chart...
Loading Chart...

103 inventors (with patents filed for the assignee):

goldMedal Jae-Hoon Kang (8 out of 16 patents)

silverMedal Hong-Sub Lee (4 out of 8 patents)

bronzeMedal Yoon-Suk Lee (4 out of 7 patents)

4.  Kyung-Sun Kim (4 out of 13 patents)

5.  Dong-Keun Song (4 out of 8 patents)

6.  Kyung Mi An (4 out of 4 patents)

7.  Gunhee Kim (3 out of 36 patents)

8.  Seung-Hun Lee (3 out of 4 patents)

9.  Sun-Young Park (3 out of 31 patents)

10.  Sung-Wook Kwon (3 out of 4 patents)

11.  Jung Ho Kim (3 out of 120 patents)

12.  Jeong-Geun Kim (3 out of 6 patents)

13.  Hong Chul Yoon (3 out of 5 patents)

14.  Te-ik Sohn (3 out of 3 patents)

15.  Changmok Oh (3 out of 3 patents)


18 patents:

1. 11970493 - Autotaxin inhibitor compounds (2024-04-30),
2. 11932618 - GLP-1 receptor agonist and use thereof (2024-03-19),
3. 11912674 - Isoxazole derivatives as nuclear receptor agonists and uses thereof (2024-02-27),
4. 11827640 - Substituted pyrazolo[1,5-a]pyrimidines as CFTR modulators (2023-11-28),
5. 11826413 - Pharmaceutical composition comprising attenuatedstrains and use thereof (2023-11-28),
6. 11806350 - Prevention and/or treatment of CNS disorders (2023-11-07),
7. 11787812 - Substituted pyrazolo[4,3-d]pyrimidines and imidazo[5,1 -f][1,2,4]triazines as androgen receptor and phosphodiesterase dual inhibitors (2023-10-17),
8. 11767311 - Acid secretion inhibitor and use thereof (2023-09-26),
9. 11731961 - Phenyl propionic acid derivatives and uses thereof (2023-08-22),
10. 11691964 - Crystalline forms of phthalazinone compound (2023-07-04),
11. 11643403 - GLP-1 receptor agonist and use thereof (2023-05-09),
12. 11268064 - RHT-3201 conjugated to polysaccharide polymer binder, and use thereof for prevention or treatment of atopic diseases (2022-03-08),
13. 11225472 - Phenyl propionic acid derivatives and uses thereof (2022-01-18),
14. 10988449 - Isoxazole derivatives as nuclear receptor agonists and uses thereof (2021-04-27),
15. 10919947 - Pharmaceutical composition containing, as active ingredient, fusion protein in which tumor-penetrating peptide and anti-angiogenesis agent are fused, for preventing and treating cancer or angiogenesis-related diseases (2021-02-16),
Il Dong Pharmaceutical Co., Ltd. is a leading pharmaceutical company based in South Korea. With a focus on research and development, Il Dong specializes in producing high-quality pharmaceutical products for a variety of medical fields. With a strong commitment to innovation and customer satisfaction, Il Dong continues to make a positive impact on the healthcare industry.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

18 Patents

#208 in Seoul

#652 in South Korea

#33,165 in the World

...
Seoul, South Korea

Il Dong Pharmaceutical Co., Ltd.

Forward Citations = 4

103 inventors:

goldMedal Jae-Hoon Kang (8 out of 16 patents)

silverMedal Hong-Sub Lee (4 out of 8 patents)

bronzeMedal Yoon-Suk Lee (4 out of 7 patents)

4.  Kyung-Sun Kim (4 out of 13 patents)

5.  Dong-Keun Song (4 out of 8 patents)

Please report any incorrect information to support@idiyas.com
Loading…